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Summary
Background:  Chlamydia  pneumoniae  heat  shock  protein  (HSP)  60  is  known  to  contribute  to
the activation  of  inﬂammation.  In  addition,  there  are  contradictory  reports  on  C.  pneumoniae
and their  role  in  activation  of  pathways  (apoptotic/antiapoptotic/necrosis)  in  coronary  artery
disease (CAD).  Hence,  more  studies  are  required  to  know  the  actual  role  of  C.  pneumoniae  in
activation  of  apoptotic/antiapoptotic/necrosis  pathways.
Methods  and  results:  In  this  study,  two  sets  of  patient  groups  (cHSP60  positive  and  cHSP60
negative) were  included  and  gene  expression  was  studied  by  cDNA  micro  array  and  real  time
polymerase  chain  reaction  arrays.  Expression  of  Caspase-3,  8,  9,  c-FLIP,  PPAR-,  PGC-1,
and Gsk-3b  were  also  evaluated  at  protein  level  by  immunoblotting.  In  cHSP60  positive  CAD
patients signiﬁcantly  higher  (p  <  0.001)  mRNA  expression  was  found  for  CCL4,  CXCL4,  CXCL9,
IL-8, CD40LG, CD8,  TGFˇ1,  TGFˇ2,  APOE,  EGR1,  CTGF,  APOB,  LDLR,  LPA, and  LPL, whereas
signiﬁcantly  lower  (p  <  0.001)  mRNA  expression  was  detected  for  CD4,  IL1F10,  IFNA2,  and  IL-
10 as  compared  to  cHSP60  negative  CAD  patients.  Additionally,  at  protein  level  expression  of
Caspase-3 (p  =  0.027),  8  (p  =  0.028),  and  9  (p  =  0.037)  were  higher  and  c-FLIP  (p  =  0.028)  and
PPAR- (p  =  0.95)  expression  were  comparable  in  cHSP60  positive  CAD  patients  compared  to
cHSP60 negative  CAD  patients.
∗ Corresponding author. Tel.: +91 011 26198 402x05; fax: +91 011 26198 401.
E-mail address: amittal cp@rediffmail.com (A. Mittal).
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Conclusion:  Genes/proteins  of  pre-apoptotic  caspase  dependent/independent  pathways,
chemokines,  and  inﬂammatory  cytokines  receptors  were  signiﬁcantly  up-regulated  in  human
atheromatous  plaques  of  cHSP60  positive  CAD  patients  suggesting  an  association  of  cHSP60  with
ardiology.  Published  by  Elsevier  Ltd.  All  rights  reserved.
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endothelial  cells,  macrophages,  and  lymphocytes.  Total  DNA
was  isolated  form  atheromatous  plaques  and  was  checked
for  the  positivity  for  C.  pneumoniae, Helicobacter  pylori,CAD.
© 2011  Japanese  College  of  C
Introduction
The  high  diversity  of  bacterial  DNA  in  coronary  lesions
supports  the  infection  hypothesis  in  the  pathophysiology
of  coronary  atherosclerosis.  The  prevalence  of  Chlamydia
pneumoniae  has  been  reported  to  be  between  0%  and  100%
in  human  plaques  by  using  various  detection  methods  [1—5].
C.  pneumoniae  has  been  detected  frequently  in  lesions  of
the  aorta,  iliac,  carotid,  and  coronary  arteries,  whereas  it
has  been  rarely  found  in  normal  arterial  tissue  [5,6]. Further,
clinical  presentation,  risk  factors,  and  inﬂammatory  status,
but  not  age,  are  important  factors  for  plaque  components
[7].  Viable  C.  pneumoniae  has  been  cultured  from  a  small
proportion  of  atherosclerotic  plaques  [8].  Further,  in  vitro
study  suggests  that  C.  pneumoniae  is  capable  of  infecting
three  cellular  components  of  the  human  vascular  wall  —
namely  endothelial  cells,  smooth  muscle  cells  (SMCs),  and
macrophages  and  can  proliferate  in  these  components  [9].
A  heat-stable  component  of  C.  pneumoniae  induces
macrophage  foam  cell  formation  and  also  stimulates  oxi-
dation  of  low-density  lipoprotein  (LDL)  [10,11].  Moreover,
molecular  mimicry  between  C.  pneumoniae  heat  shock  pro-
tein  (HSP)  60  antigens  and  human  HSP60  has  been  reported
and  also  suggests  a  role  in  the  activation  of  inﬂamma-
tion  [12]. Streblow  et  al.  reported  that  accumulation  of
lipids  is  thought  to  be  both  an  initiator  and  accelerator  for
atherosclerosis  plaque  formation  [13,14].  Additionally,  C.
pneumoniae  has  been  reported  to  alter  the  lipid  metabolism
of  infected  SMCs  and  macrophages  [13]. Also,  C.  pneumo-
niae  infection  increases  endothelial  expression  of  adhesion
molecules,  which  signiﬁcantly  enhances  trans  endothelial
migration  of  inﬂammatory  cells  [15,16].  These  inﬂamma-
tory  processes  are  orchestrated  in  part  by  chemokines,
which  participate  in  the  inﬂammatory  process  by  mediating
monocyte  recruitment  to  the  sites  of  injury,  vascular  SMC
proliferation,  neovascularization,  and  platelet  activation
[17].  Peroxisome  proliferator-activated  receptor-  (PPAR)
regulates  lipid,  lipoprotein  metabolism,  and  glucose  homeo-
stasis  and  is  up  regulated  after  C.  pneumoniae  infection
[18,19].  Moreover,  caspases  are  present  in  nucleated  cells  as
inactive  zymogens  (pro-caspases)  and  get  activated  in  apop-
totic  pathways  [20—22]. Two  tiers  of  different  caspases  are
consecutively  activated,  such  as  signal,  initiator  caspases
(mainly  caspase-8  and  9)  and  effector  caspases  (caspase-
3)  [20]. Cytotoxicity  associated  with  chlamydial  infection  is
well  recognized  and  has  been  linked  to  induction  of  apo-
ptosis  [21]. However,  controversy  exists  as  to  the  nature
of  the  apoptotic  mechanisms,  and  more  than  one  route  for
cell  death  may  be  utilized  depending  on  the  host  cell  type
involved,  epithelial  cell  versus  macrophage  [21].
There  are  contradictory  reports  on  C.  pneumonia-
induced  activation  of  apoptotic/antiapoptotic  pathways;
even  some  researchers  hypothesized  that  C.  pneumoniae
may  induce  necrosis  in  host  cells.  The  reason  for  these
c
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Tontroversial  results  may  be  because  these  studies  have
een  conducted  on  different  cell  lines  and  their  modes
f  activation  could  therefore  vary  [20,23,24]. Further,  in
rder  to  get  a  real  picture,  human  studies  are  required  to
now  the  role  of  C.  pneumoniae  on  activation  of  signal-
ng  pathways  in  CAD.  Hence,  for  the  ﬁrst  time  we  have
erformed  this  study  on  human  atherosclerotic  plaques
nd  evaluated  signaling  pathways  including  atherosclerosis
elated  genes,  cytokine  and  chemokine  receptor  genes,  apo-
tosis  and  antiapoptotis-related  genes  at  RNA  level  using
icro  array  and  polymerase  chain  reaction  (PCR)  arrays  and
rotein  levels  by  immunoblotting  in  cHSP60  positive  and
egative  CAD  patients.
aterials and methods
nless  otherwise  stated,  all  the  reagents  were  purchased
rom  Sigma  Aldrich  (Saint  Louis,  MO,  USA)  and  antibodies
rom  Cell  Signaling  (Cell  Signaling  Technology,  Beverly,  MA,
SA).  Plastic  wares  and  glass  wares  for  all  tissue-related
orks  were  obtained  from  Greiner  Bio-one,  Frickenhausen,
ermany.
atient  enrollment,  atheroma  collection  and
andling
orty  patients  (28  men,  12  women)  mean  age  51  ±  13  years
ttending  the  Department  Of  Cardiothoracic  &  Vascular
urgery,  Safdarjung  Hospital,  New  Delhi  from  September
007  to  April  2008  were  enrolled  in  the  study.  Prior  informed
ritten  consent  was  obtained  from  each  patient.  The  study
eceived  clearance  from  the  ethical  committee,  Safdarjung
ospital.  Atheromatous  tissues  (coronary  artery)  were  col-
ected  in  aseptic  conditions  and  placed  in  30  ml  of  transport
edium  immediately  upon  resection.  The  detailed  proce-
ure  of  atheroma  collection  and  handling  are  as  described
arlier  [25].
theroma  histology,  DNA  and  RNA  isolation  and
esting
istological  examination  of  atheromatous  tissues  by  hema-
oxylin  and  eosin  staining  revealed  lipid  core,  a lesion  with
brosis,  large  areas  of  calciﬁcation  with  inﬁltration  of  SMCs,ytomegalovirus  (CMV),  and  herpes  simplex  virus-1  (HSV-
)  using  multiplex  real  time  PCR  as  described  earlier  [26].
otal  RNA  from  the  coronary  artery  atheroma  samples  was
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Table  1  Baseline  clinical  characteristics  of  cHSP60  positive  and  cHSP60  negative  coronary  artery  disease  patients.
Baseline  characteristics  cHSP60  positive  (n  =  18)  cHSP60  negative  (n  =  22)  p-value
Age  (years)  53  ±  11  50  ±  12  NS
Male 12  (66.6%)  14  (63.6%)  NS
Female 05  (27.7%)  07  (31.8%)  NS
HT 13  (72.2%)  12  (54.5%)  NS
DM 07  (38.8%)  04  (18.2%)  NS
Smoking 13  (72.2%)  12  (54.5%)  NS
Non-alcoholic 16  (88.8%) 16  (72.7%)  NS
SLS 12 (66.6%) 11  (50%) NS
; DM,
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ScHSP, Clamydia pneumoniae heat shock protein; HT, hypertension
solated  using  RNeasy  ﬁbrous  tissue  mini  kit  (Qiagen  Sci-
nces,  Germantown,  MD,  USA)  and  the  concentration  was
etermined  by  a  RNA  dye-binding  assay  (Pico-Green,  Molec-
lar  Probes,  Eugene,  OR,  USA).  For  cDNA  synthesis,  RETRO
cript  (Ambion  Inc.,  Austin,  TX,  USA)  was  used  as  per  man-
facturer’s  instructions.
lassiﬁcation  of  cHSP60  positive  and  negative  CAD
atients
he  clinical  characteristics  of  cHSP60  positive  and  cHSP60
egative  CAD  patients  are  presented  in  Table  1.  Monoplex
everse  transcriptase  (RT)  PCR  was  performed  for  detect-
ng  positivity  for  C.  pneumoniae  using  C.  pneumoniae  HSP60
ene  in  CAD  patients  who  were  earlier  detected  positive
or  C.  pneumoniae  speciﬁc  16S  rRNA.  Primers  and  probes
sed  for  ampliﬁcation  and  checking  speciﬁcity  were  custom
esigned  (Applied  Biosystems,  Foster  City,  CA,  USA).  Fur-
her,  study  was  performed  only  on  cHSP60  positive  (n  =  5)
negative  for  H.  pylori, CMV,  and  HSV-1)  and  cHSP60  nega-
ive  (n  =  4)  (also  negative  for  H.  pylori, CMV,  and  HSV-1)  CAD
atients.
icroarray  experiment
ustomized  services  for  microarray  were  performed  at  Oci-
um  Biosolution  (Hyderabad,  India).  There  were  40  K  human
enes  spotted  on  slides  and  hybridized  with  Cy3  and  Cy5
ye  in  single  color.  Atheromatous  plaques  from  coronary
rtery  obtained  from  CAD  patients  who  were  positive  for  C.
neumoniae  only  (H.  pylori  and  CMV  negative)  were  treated
s  test  samples  and  those  obtained  from  CAD  patients
egative  for  C.  pneumoniae  (H.  pylori  and  CMV  negative)
ere  treated  as  control  samples.  All  experimental  proce-
ures  (including  hybridization,  scanning)  were  performed
t  Ocimum  laboratory  followed  by  data  analysis  through
ioinformatics  approach.  Detailed  protocol  is  available  on
eb  portal,  GEO  accession  number:  GSE19590.  Further,  we
alidated  these  data  by  real  time  RT-PCR  using  PCR  arrays
t  RNA  level  and  using  immunoblotting  at  protein  levels.uantitative  real  time  RT-PCR  arrays
ene  expression  was  studied  using  inﬂammatory  cytokine
nd  receptor  PCR  array  and  atherosclerosis  PCR  array  —
l
t
A
B diabetes mellitus; SLS, sedentary lifestyle; NS, non signiﬁcant.
focused  gene  expression  proﬁling  PCR  array’  for  human  as
er  manufacturer’s  instructions  (SABiosciences  Corporation,
rederick,  MD,  USA).  All  information  about  quantitative  real
ime  RT  PCR  arrays  was  previously  reported  [25].
mmunoblotting
ne  piece  of  atheromatous  plaque  (coronary  artery)  was
omogenized  through  mortar-pestle  with  the  help  of  liquid
itrogen  and  subsequently  treated  with  lysis  buffer  [0.5%
onidet  P-40,  150  mM  NaCl,  0.1%  sodium  dodecyl  sulfate
SDS),  50  mM  NaF,  1  mM  Na3VO4,  and  1  mM  phenyl  methyl  sul-
onyl  ﬂuoride]  containing  the  complete  protease-inhibitor
ocktail  (Roche  Diagnostics,  Mannheim,  Germany).  Protein
oncentration  was  determined  by  the  Bradford  protein  assay
BioRad  Laboratories,  Hercules,  CA,  USA)  with  BSA  as  stan-
ard.  Extracted  proteins  (60  g)  were  electrophoresed  on
—12%  SDS  polyacrylamide  gels  and  transferred  to  polyvinyl
iﬂuoride  membranes  (BioRad  Laboratories).  The  mem-
ranes  were  reversibly  stained  with  ponceau  S  (Sigma
ldrich)  to  conﬁrm  complete  transfer.  Membranes  were
locked  with  5%  nonfat  dry  milk  in  PBS-Tween-20  and  incu-
ated  with  rabbit  polyclonal  anti-IgGs  against  Caspase-3,  8,
,  c-FLIP, PPAR-, PGC-1˛,  Gsk3b, and  beta  actin  and  further
ncubated  with  the  monoclonal  goat  anti-rabbit  IgG  conju-
ated  with  horseradish  peroxidase.  Subsequently,  they  were
eveloped  using  diaminobenzamide  as  the  detection  agent
nd  analyzed  using  the  Image  J  software  (NIH,  Bethesda,
D,  USA)  (http://rsbweb.nih.gov/ij/index.html). Represen-
ative  blots  are  shown  in  the  results  section.
tatistical  analysis
PSS  version  12.0  for  Windows  (SPSS  Inc.,  Chicago,  IL,  USA)
as  used  for  statistical  testing.  Continuous  variables  were
nalyzed  with  the  two-sample  t  test  (in  the  case  of  normal
istribution)  or  the  Mann—Whitney  U  rank-sum  test.
imultaneously,  an  alpha  level  of  0.05  was  set  as  the
evel  of  signiﬁcance.  Image  J  software  was  used  for
he  calculation  of  immunoblot  band  area  in  all  groups.
nalysis  of  microarray  data  was  performed  at  Ocimum
iosolution.
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RFigure  1  (a)  Human  inﬂammatory  cytokine  and  chemokine  rec
patients. (b)  Human  atherosclerosis  signaling  genes  in  cHSP60  po
pneumoniae  heat  shock  protein.
Results
Microarray  experiment  on  human  40K  genes  in
cHSP60  positive  and  negative  CAD  patientsThere  were  437  genes  which  were  up  regulated  and  330
genes  were  down  regulated  in  cHSP60  positive  patients  com-
pared  to  cHSP60  negative  CAD  patients.  GMCSF, LPL,  TGF-ˇ
receptor,  ICAM1  receptor,  IL-8, NF-kB, APOA1  and  VEGF
T
w
pr  genes  in  cHSP60  positive  and  negative  coronary  artery  disease
 and  negative  coronary  artery  disease  patients.  cHSP,  Clamydia
ere  signiﬁcantly  (p  <  0.001)  up  regulated  in  cHSP60  posi-
ive  CAD  patients  compared  to  cHSP60  negative  CAD  patients
Table  2).
eal  time  RT-PCR  arrayswo  constitutive  genes  (B2-microtubulin  and  beta  actin)
ere  used  in  all  experiments  as  uniform  expression
attern  was  observed  for  both  the  genes  (out  of  5
220  H.C.  Jha  et  al.
Table  2  Comparison  of  Clamydia  pneumoniae  heat  shock  protein  60  positive  and  negative  in  micro  array  and  polymerase  chain
reaction array  (PCR)  experiments.
S.No.  Genes  Micro  array  PCR  array
Up-regulated  Down-regulated  Up-regulated  Down-regulated
1  GMCSF  6.6  2.9
2 LPL  6.6  6.6
3 SMAD  5.3  9
4 TGF-  receptor  4.5  5.2
5 TNFAIP3  3.64  4.2
6 ICAM-1  receptor  9.5  5.2
7 IL-8 9.4  11.8
8 TNF- 9.4 4.3
9 IL-1 6.6  4.3
10 NF-kB  5.2  5.3
11 PRDX1  3.6  12.2
12 GABA 3.2  11
13 VEGF 9.2  3.6
14 APOA 6.4 4.2
15 COL9A1 7.8  4.8
16 BRCA1 5.4  8.1
17 TP72 2.8  3.2
GMCSF, granulocyte-macrophage colony-stimulating factor; LPL, lipoprotein lipase; SMAD, Caenorhabditis elegans mothers against
decapentaplegic; TGF-, transforming growth factor beta; TNFAIP3, tumor necrosis factor, alpha-induced protein 3; ICAM-1, inter-
cellular adhesion molecule 1; IL-8, interleukin-8; NF-Kb, nuclear factor kappa-light-chain; PRDX1, peroxiredoxin-1; GABA, -aminobutyric
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Bacid; VEGF, vascular endothelial growth factor; APOA, apolipopr
alpha-1(IX) chain.
onstitutive  genes)  in  cHSP60  positive  and  negative  CAD
atients.
a)  Human  inﬂammatory  cytokines  and  receptors  PCR  array
genes  in  cHSP60  positive  and  negative  CAD  patients
In  our  study  CCL2, CCL3, CCL4, CCL5, CCL20, CCL21,
CCL23, CCL24, CEBPB, CRP, IL-13RA,  CXCL12,  CXCL1,
CXCL9,  IL-8, CD40LG  were  signiﬁcantly  (p  <  0.001)  up-
regulated  while  IL1F10  and  IFNA2  were  signiﬁcantly
(p  <  0.001)  down  regulated  in  cHSP60  positive  CAD
patients  compared  to  cHSP60  negative  CAD  patients
(Fig.  1a).
)  Human  atherosclerosis  PCR  array  genes  in  cHSP60  posi-
tive  and  negative  CAD  patients
CCL2,  CCL5, TGFB1,  TGFB2,  APOE, EGR1, CTGF, APOB,
LDLR,  LPA, LPL, PDGFRB,  and  VEGFA  were  signiﬁcantly
(p  <  0.001)  up  regulated  while  ELN, CSF2, SERP1NB2,  and
SOD1  were  signiﬁcantly  down  regulated  (p  <  0.001)  in
cHSP60  positive  CAD  patients  compared  to  cHSP60  nega-
tive  CAD  patients  (Fig.  1b).
rotein  expression  proﬁles  in  cHSP60  positive  and
egative  CAD  patients
eta  actin  was  used  for  normalization  of  protein  pro-
le  expression  in  all  experiments.  Expression  of  Caspase-3
p  =  0.027),  8  (p  =  0.028),  and  9  (p  =  0.037)  were  higher
hile  expression  of  c-FLIP  (p  =  0.028)  was  lower  and
xpression  of  PPAR  (p  =  0.95)  was  comparable  in  cHSP60
ositive  CAD  patients  compared  to  cHSP60  negative  CAD
atients.  Expression  of  PGC-1  ˛ (p  =  0.026),  and  Gsk3b
c
P
o
c A-I; COL9A, vascular endothelial growth factor; BRCA, collagen
p  =  0.024)  was  also  higher  in  cHSP60  positive  CAD
atients  compared  to  cHSP60  negative  CAD  patients
Figs.  2—5).
iscussion
.  pneumoniae  infection  causes  increased  LDL  uptake  in
acrophages,  with  a  subsequent  increase  in  foam  cell  for-
ation  [26]. The  ability  of  pathogens  to  increase  lipid
ccumulation  in  macrophages  and  SMCs  is  an  important
tep  in  accelerating  atherosclerosis  [13,27].  C.  pneumoniae
s  able  to  disseminate  via  the  circulation  throughout  the
ody  within  monocytes  and  through  this  way  it  can  enter
therosclerotic  lesions  [26]. Earlier  we  reported  higher  anti-
ody  levels  of  C.  pneumoniae  IgA  in  the  sera  of  CAD  patients
28],  and  also  detected  higher  positivity  for  C.  pneumo-
iae  in  comparison  to  other  pathogens  in  atheromatous
laques  of  CAD  patients  using  real  time  PCR  [25]. Infec-
ion  of  monocytes  with  C.  pneumoniae  increases  adherence
f  infected  monocytes  to  endothelial  cells  [29]  and  pro-
otes  LDL  oxidation  [30], resulting  in  accelerated  uptake
f  cholesterol  by  macrophages  and  subsequent  foam  cell
ormation  [26]. Increased  LDL  oxidation  was  also  observed
pon  infection  of  endothelial  cells  with  C.  pneumoniae  [26].
n  this  study  we  have  shown  that  CAD  patients  positive
or  cHSP60  have  higher  levels  of  lipid  transporter  (APO-A,
,  and  E)  and  lipid  signaling  molecules  (LDLR, LPL,  LPA)
ompared  to  cHSP60  negative  CAD  patients.  Microarray  and
CR  array  results  support  the  enhancement  of  VEGFA  and
ther  lipid  transporters  as  well  as  lipid  signaling  genes  in
HSP60  positive  CAD  patients.  Monocyte  recruitment  into
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Figure  2  Immunoblotting  of  PPAR-gamma  and  caspase-3  in  cHSP60  positive  and  negative  CAD  patients.  PPAR,  peroxisome
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cproliferator-activated  receptor;  cHSP,  Clamydia  pneumoniae  he
the  arterial  wall  in  response  to  injury  is  a  multistep  pro-
cess  that  involves  reversible  adhesion  of  monocytes  to
the  endothelium,  activation  of  monocytes,  ﬁrm  adherence,
and,  ﬁnally,  migration  to  the  sub  endothelial  space  through
endothelial  cell  junctions  [31]. A  higher  level  of  VEGFA
might  be  associated  with  these  multistep  processes  [32].
Therefore,  whether  LDL-loaded  macrophages  with  C.  pneu-
moniae  infection  have  any  effect  on  cell  death  and,  if  so,
whether  this  death  occurs  by  apoptotic/necrotic,  caspase-
dependent/independent  pathways  were  investigated  in  our
study.  Apoptosis  is  a  highly  regulated  cellular  process  that
consists  of  diverse  upstream  private  pathways  for  trans-
ducing  extracellular  death  signals  into  intracellular  events
and  a  common  downstream  effector  pathway  for  ampliﬁ-
cation  of  caspases  [33]. In  human  atherosclerotic  lesions,
enhanced  expression  of  cHSP60  has  been  detected  [34].
Despite  the  inhibitory  effect  that  Chlamydia  infection  has
p
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Figure  3  Immunoblotting  of  caspase-8  and  caspase-9  in  cHSP60  
Clamydia pneumoniae  heat  shock  protein;  Cp,  Clamydia  pneumoniaock  protein;  Cp,  Clamydia  pneumonia.
n  apoptosis  induced  by  various  agents,  some  ﬁndings  sug-
est  a  putative  role  for  caspase-dependent  apoptosis  in
preading  infection  [35]. On  the  other  hand,  it  has  been
eported  that  chlamydiae  are  capable  of  inducing  cell  death
ia  caspase-independent  pathways  [36]. In  our  study,  lev-
ls  of  caspase  3,  8,  and  9  were  higher  whereas  levels  of
-FLIP  and  PPAR-  ˛ and  -  were  lower  in  cHSP60  positive  CAD
atients.  Earlier  Dean  et  al.  and  Fischer  et  al.  had  reported
hat  C.  pneumoniae  infection  down  regulates  pro-apoptotic
ytoplasmic  proteins  such  as  caspase-3  and  cytochrome  c
23,37].  Moreover,  it  has  been  found  that  the  regulatory
aspase-8  is  directly  activated  by  death  receptors,  whereas
aspase-9  activation  follows  mitochondrial  stress  [38]. Both
athways  merge  by  activating  executioner  caspase-3  [39].
t  has  been  suggested  that  different  proapoptotic  and  anti-
poptotic  proteins  participate  in  the  regulation  of  apoptosis
40].
positive  and  negative  coronary  artery  disease  patients.  cHSP,
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Figure  4  Immunoblotting  of  c-FLIP  and  PGC1-  in  cHSP60  positive
pneumoniae heat  shock  protein;  Cp,  Clamydia  pneumonia.
Hence,  this  study  reveals  that  cHSP60  positive  CAD
patients  show  higher  expression  of  pre  apoptotic  rather
than  necrotic-related  genes  or  proteins.  Further,  expres-
sion  of  genes  or  proteins  related  to  both  caspase  dependent
and  independent  pathways  were  higher  in  cHSP60  positive
CAD  patients  compared  to  cHSP60  negative  CAD  patients.
In  contrast  to  this,  Hauer  et  al.  reported  that  both  live
and  inactivated  forms  of  C.  pneumoniae  induce  a  necrotic
form  of  cell  death  which  augments  the  apoptotic  cell
Figure  5  Immunoblotting  of  Gsk3b  in  cHSP60  positive  and
negative  coronary  artery  disease  patients.  cHSP,  Clamydia  pneu-
moniae  heat  shock  protein;  Cp,  Clamydia  pneumonia.
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eath  induced  by  the  accumulation  of  oxidized  LDL  by
acrophages  [26]. Also  Dean  et  al.  hypothesized  that  C.
neumoniae  infection  activates  antiapoptotic  proteins  [37].
dditionally,  Fischer  et  al.  suggested  that  Chlamydia  can
oth  induce  and  inhibit  apoptosis  [23]. It  is  easily  conceiv-
ble  that  chlamydial  infection  can  result  in  apoptosis  in  one
onstellation  of  cell  type  and  bacterial  strain  but  not  in
ther  combinations  [20]. Further,  it  has  been  reported  that
hlamydia  infection  of  an  organ  can  lead  to  a local  immune
esponse  followed  by  systemic  activation  of  auto  reactive
 and  B  lymphocytes  [41]. T  cells,  macrophages,  and  mast
ells  inﬁltrate  the  lesion  and  are  particularly  abundant  in
he  shoulder  region  where  the  atheroma  grows  [42]. In  our
tudy,  expression  of  CD8  was  higher  while  expression  of  CD4
as  lower  in  cHSP60  positive  CAD  patients.  Moreover,  CD8+
 cells  restricted  by  major  histocompatability  complex  class
 antigens  are  also  present  in  atherosclerotic  lesions  [43].
alme  et  al.  suggested  that  C.  pneumoniae-induced  T-cell
ctivation  seemed  to  be  linked  with  CD8  cells  during  the
ctive  stage  of  infection  [44]. Also,  Loomis  et  al.  reported
hat  CD8+  T  cells  play  a  critical  role  in  protection  against
ost  intracellular  pathogens,  including  Chlamydia  [45].
T-Bet  has  been  identiﬁed  as  a  Th1  cell-speciﬁc  factor  that
nduces  the  production  of  IFN- by  developing  Th2  cells  [46].
ATA3  is  a  zinc-ﬁnger  transcription  factor  and  is  crucial  for
nducing  key  attributes  of  Th2  cells  including  transcriptional
ompetence  of  the  Th2  cytokine  cluster,  which  includes  the
enes  encoding  IL-13, IL-4, and  IL-5  [47]. Again  in  this  study
e  found  that  CAD  patients  with  atheromatous  plaques  sup-
ort  the  Th2-mediated  response  as  expression  of  GATA3  is
igher  and  T-Bet  is  lower  in  cHSP60  positive  CAD  patients.
arlier  in  our  study,  a  similar  pattern  was  found  in  serum  of
AD  patients  [48]. Pro-inﬂammatory  molecules  are  actively
nvolved  in  the  activation  and  migration  of  leukocytes  to
ites  of  vascular  injury  and  inﬂammation  [49]. Our  study  also
emonstrates  that  cHSP60  positive  CAD  patients  have  higher
xpression  of  cytokine  and  chemokine  receptors.  Expression
f  IL-8,  TGF- receptor,  ICAM1  receptor,  TNF-˛, IL-1, NF-
B,  CCL3, CCL4, CXCL3, CXCL4, CCR5, IL1B, CXCL9, CXCR3,
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CCL23,  CCL24, and  CCL25  were  higher  whereas  expression
of  IL-10, IL-10RA,  IL1F10, IL1A, and  IFNA2  were  lower  in
cHSP60  positive  CAD  patients.  Although  C.  pneumoniae  is
known  to  preferentially  infect  the  epithelial  tissue  of  the
respiratory  tract,  this  bacterium  can  also  multiply  in  vitro  in
monocytes/macrophages,  T  lymphocytes,  endothelial  cells,
and  aortic  SMCs  [50]. Earlier  Mueller  et  al.  reported  that
CXCL4  can  induce  signaling  in  activated  T  lymphocytes,
which  results  in  their  chemotactic  migration  and  also  sug-
gested  a  role  of  CXCL4  in  T  cell-mediated  immunoregulation
[51].  It  has  also  been  reported  that  CXCL4  can  induce  differ-
ential  regulation  of  the  transcription  factors  like  T-bet  and
GATA-3,  suggesting  an  ability  to  modulate  Th1/Th2  polariza-
tion  [52]. CXCR7  is  a  highly  conserved  chemokine  receptor
that  binds  with  high  afﬁnity  to  the  chemokine  CXCL12  [53].
Similar  to  the  other  CXCL12  receptor  CXCR4, CXCR7  are
widely  expressed  and  play  a  role  in  fetal  development  [54].
During  the  course  of  a  bacterial  infection,  the  bacterial
DNA  acts  as  a  potent  adjuvant  facilitating  the  activation
of  auto  aggressive  T  cells  [55]. The  macrophages  may
adhere  to  coronary  vessels,  for  example,  where  they  can
cause  chronic  cytokine-mediated  inﬂammatory  reactions
inﬂicting  direct  endothelial  damage  [56]. There  is  evi-
dence  of  molecular  mimicry  between  bacterial  antigens  and
heart  speciﬁc  proteins  indicating  that  bacterial  peptides
can  trigger  tissue-speciﬁc  inﬂammation  of  the  heart  [57].
Lipid-loaded  macrophages  (foam  cells)  are  a  major  cellular
component  of  atherosclerotic  lesions  and  chronic  infection
of  foam  cells  with  C.  pneumoniae  could  exacerbate  the
inﬂammatory  response  which  is  associated  with  the  initi-
ation  and  progression  of  atherosclerotic  lesions  [58]. Earlier
correlative  studies  have  supported  a  possible  link  between
atherosclerosis  and  chronic  or  persistent  infection  of  C.
pneumoniae  [59].
Earlier  records  and  literature  [60]  point  towards  an
inﬂammatory  basis  and  potential  etiological  role  for  var-
ious  infective  agents,  speciﬁcally  C.  pneumoniae, in  the
pathogenesis  of  atherosclerosis.  From  animal  and  human
pathological  specimen  examinations,  micro-organisms  are
found  to  exist  preferentially  in  atheromatous  tissues.  C.
pneumoniae  has  been  shown  to  promote  the  process  of
atherosclerosis  through  a  variety  of  immunological  mech-
anisms.  Another  possible  mechanism  of  damage  is  that  C.
pneumoniae  infection  may  stimulate  an  increase  in  tissue
factor  activity  and  platelet  adhesion,  and  thus  promote
thrombogenicity.  Infection  in  monocytes  or  macrophages,
endothelial  cells  and  vascular  SMCs  have  been  shown  to
induce  pro-inﬂammatory  and  pro-coagulant  protein  pro-
duction  (tissue  factor,  plasminogen  activator  inhibitor-1,
MCP-1),  through  the  activation  of  nuclear  trancription  fac-
tors  such  as  NF-kB  in  these  cells.  Further,  Chlamydial
hsp  60  could  also  activate  macrophage  TNF- and  matrix
metalloproteinases,  which  are  enzymes  that  can  cause
connective  tissue  degradation  and  atherosclerotic  plaque
rupture.  Viable  C.  pneumoniae  have  also  been  cultured
from  atheromatous  plaques,  suggesting  a  more  causal  rela-
tionship.  In  contrast,  C.  pneumoniae  antigens  were  not
detectable  in  normal  arterial  walls  or  non-atherosclerotic
arterial  segments  in  people  known  to  have  atherosclerosis.
Hence,  beneﬁts  of  the  secondary  prevention  of  atherosclero-
sis  have  been  demonstrated  in  some  antibiotic  intervention
studies  for  C.  pneumoniae.
[223
In conclusion,  in  this  study  using  human  atheroma-
ous  plaque  at  RNA  and  protein  levels,  it  is  demon-
trated  that  genes/proteins  of  pre  apoptotic  caspase-
ependent/independent  pathways,  chemokine,  and  inﬂam-
atory  cytokine  receptors  were  upregulated  in  cHSP60
ositive  CAD  patients  showing  cHSP60  association  with  CAD
nd  suggests  its  role  in  progression  of  CAD.  The  limitation  of
he  present  study  is  that  using  homogenized  tissue  samples
nly  the  gene  and  protein  expressions  of  various  molecules
elated  to  cell  death  signaling  and  inﬂammation  were  evalu-
ted.  Therefore,  it  is  uncertain  in  which  cell  types  the  death
ignaling  is  activated.  In  addition,  protein  expressions  of  cer-
ain  enzymes  such  as  caspases  do  not  always  represent  the
nzyme  activities.
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